Composite preparation for lowering viral load of AIDS patients and enhancing T lymphocyte CD4 immunity and application thereof

A viral load and compound preparation technology is applied in antiviral agents, applications, and medical preparations containing active ingredients. The effect of rich sources and a long history of medicinal use

Inactive Publication Date: 2017-05-17
青岛海能海洋生物技术有限公司
View PDF4 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Nucleosides and non-nucleosides more than 20 kinds of antiviral chemical drugs or cocktail therapy (HAART), which are widely used in the world, only have a certain inhibitory effect on HIV replicase (HIV: reverse transcriptase, protease), but have a certain inhibitory effect on infected HIV. Infected ce

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Example Embodiment

[0031] Example 1

[0032]According to the compound preparation formula, weigh 12 parts of Angelica sinensis, 14 parts of wolfberry fruit, 8 parts of almond, 10 parts of licorice, 9 parts of Cistanche deserticola, 7 parts of Morinda officinalis, 15 parts of sea cucumber, 36 parts of sea cucumber, 14 parts of abalone, and 11 parts of oyster. parts, 25 parts of seaweed, 8 parts of ginsenosides and 10 parts of icari saponins, including 18 parts of female sea cucumber and 18 parts of male sea cucumber, respectively extract the eggs of female sea cucumber and the male essence cells of male sea cucumber. The main components in the extract of female sea cucumber eggs include: Acidic mucopolysaccharide 33%, chondroitin sulfate 27%, astaxanthin 26%, selenium 14%; the main components of male sea cucumber after extracting male essence cells include arginine 29%, collagen 71%; the angelica, wolfberry fruit , almonds, licorice, Cistanche, Morinda officinalis, and leaves as traditional Chine...

Example Embodiment

[0033] Example 2

[0034] According to the formula of compound preparation, weigh 10 parts of Angelica sinensis, 12 parts of wolfberry fruit, 6 parts of almond, 12 parts of licorice, 11 parts of Cistanche deserticola, 5 parts of Morinda officinalis, 13 parts of sea cucumber, 16 parts of abalone, 13 parts of oyster parts, 20 parts of seaweed, 6 parts of ginsenosides, 12 parts of icari saponins, including 15 parts of female sea cucumber and 15 parts of male sea cucumber.

Example Embodiment

[0035] Example 3

[0036] According to the compound preparation formula, weigh 13 parts of Angelica sinensis, 16 parts of wolfberry fruit, 6 parts of almond, 10 parts of licorice, 10 parts of Cistanche deserticola, 6 parts of Morinda officinalis, 14 parts of sea cucumber, 12 parts of abalone, 11 parts of oyster parts, 25 parts of seaweed, 8 parts of ginsenosides, 10 parts of icari saponins, including 20 parts of female sea cucumber and 20 parts of male sea cucumber.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention provides a composite preparation for lowering viral load of AIDS patients and enhancing T lymphocyte CD4 immunity. The compound of the extracted female sea cucumber ova and male sea cucumber essence active cells and the traditional Chinese medicine extract is used as the effective active ingredient to form the composite preparation. Angelica, wolfberry fruit, almond, licorice root, broomrape, Morinda officinalis and epimedium are used as main traditional Chinese medicine raw materials; and the composite preparation is also composed of sea cucumbers, abalones, oysters, algae, ginsenoside and epimedium saponin essence. The invention also provides application of the composite preparation. The composite preparation can efficiently eliminate or reduce the HIV load, is capable of enhancing the T lymphocyte CD4 immunity and restoring the immunologic function, effectively aims at the HIV-infected cells of the host, and greatly lowers the viral load. After the medicine is stopped, the viral load does not rebound, and the AIDS patient can obviously recover; and the composite preparation can be widely used in the field of medicine industry.

Description

technical field [0001] The invention belongs to the technical field of functional food, and in particular relates to a compound preparation for reducing the viral load of AIDS patients and improving CD4 immunity of T lymphocytes and its application. Background technique [0002] AIDS, that is, Acquired Immunodeficiency Syndrome (AIDS), is under the direct or indirect action of human immunodeficiency virus, T cell immunodeficiency, and other immune cells are damaged to varying degrees, prompting various serious opportunities Sexual infections and tumors occur, leading to death. AIDS has not only become a public health problem that seriously threatens people's health, but also affects economic development and social stability. Modern medicine prevents and treats AIDS by anti-virus, improving body immunity, controlling and treating various opportunistic infections, but the drug has a single effect and often requires multiple drugs, which are expensive and have severe side effe...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K36/815A61P31/18A61P37/04A23L33/10A23L17/50A23L17/00A23L17/60A23L2/38A61K31/704A61K31/7048A61K35/616A61K35/618
CPCA23L2/38A61K31/704A61K31/7048A61K35/616A61K35/618A61K36/02A61K36/232A61K36/296A61K36/484A61K36/64A61K36/736A61K36/746A61K36/815A23V2002/00A61K2300/00A23V2200/30A23V2200/324
Inventor 程玉山
Owner 青岛海能海洋生物技术有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products